Differential gene expression identified in Uigur women cervical squamous cell carcinoma by suppression subtractive hybridization

Neoplasma

Volumn 57, Issue 2, 2010, Pages 123-128

  Pan, Z ^a,b   Chen, S ^a   Pan, X ^a   Wang, Z ^a   Han, H ^a   Zheng, W ^a   Wang, X ^a   Li, F ^a   Qu, S ^b   Shao, R ^c  

^a SHIHEZI UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cervical tumor; Gene expression; Suppression subtractive hybridization; Uigur women squamous cell carcinoma

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 5; ANNEXIN A8; BCL2 ASSOCIATED ATHANOGENE; CYTOCHROME C1; CYTOKERATIN 8; DNAJ HOMOLOG SUBFAMILY C MEMBER 9; EPHRIN B1; EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 ALPHA 1; EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 ALPHA 2; FATTY ACID BINDING PROTEIN 4; FIBROBLAST GROWTH FACTOR 1; FORTY TWO THREE DOMAIN CONTAINING 1 TRANSCRIPT VARIANT 2; GROWTH DIFFERENTIATION FACTOR 15; HERMES ANTIGEN; INHIBITOR OF DIFFERENTIATION 3; K RAS PROTEIN; NEUROBLASTOMA BREAKPOINT FAMILY MEMBER 1 PROTEIN; PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS T; PROTEIN; PTK6 PROTEIN TYROSINE KINASE 6; RAN BINDING PROTEIN 2; RIBOSOMAL PROTEIN L26; RIBOSOMAL PROTEIN L30; RIBOSOMAL PROTEIN L31; RIBOSOMAL PROTEIN L39; RIBOSOME PROTEIN L3; SET DOMAIN CONTAINING 5 PROTEIN; SMALL PROLINE RICH PROTEIN 3; THYMOPOIETIN; TRANSMEMBRANE PROTEIN 70; UNCLASSIFIED DRUG; MESSENGER RNA; TUMOR MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; UPREGULATION; UTERINE CERVIX CARCINOMA; CANCER STAGING; CHINA; ETHNOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ADULT; CARCINOMA, SQUAMOUS CELL; CHINA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 77953634772     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_02_123     Document Type: Article

References (19)

1. JEMAL A, SIEGEL R, WARD E et al. Cancer Statistics 2006. CA Cancer J Clin 2006; 56: 106-130. doi:10.3322/ canjclin.56.2.106
2. MAMMAS IN, ZAFIROPOULOS A, KOUMANTAKIS E et al. Transcriptional activation of H-and N-ras oncogenes in human cervical cancer. Gynecol Oncol 2004; 92: 941-948. doi:10.1016/j.ygyno.2003.11.040
3. KANAO H, ENOMOTO T, KIMURA T et al. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer. Cancer Res 2005; 65: 8640-8645. doi:10.1158/0008-5472.CAN-04-4112
4. LIU FS, CHEN JT, DONG JT et al. KAI1 metastasis suppressor gene is frequently down-regulated in cervical carcinoma. Am J Pathol 2001; 159: 1629-1634.
5. LEE JW, SONG SY, CHOI JJ et al. Decreased galectin-3 expression during the progression of cervical neoplasia. J Cancer Res Clin Oncol 2006; 132: 241-247. doi:10.1007/s00432-005-0069-1
6. DE-CASTRO ARCE J, GÖCKEL-KRZIKALLA E, RÖSL F. Retinoic acid receptor beta silences human papillomavirus-18 oncogene expression by induction of de novo methylation and heterochromatinization of the viral control region. J Biol Chem 2007; 282: 28520-28529. doi:10.1074/jbc.M702870200
7. WANG PH, CHEN GD, CHANG H et al. High expression of human telomerase reverse transcriptase in high-grade intraepithelial neoplasia and carcinoma of uterine cervix and its correlation with human papillomavirus infection. Reprod Sci 2007; 14: 338-348. doi:10.1177/1933719107303986
8. ZEMIN PAN, JUN LI, XIAOLIN PAN et al. Methylation of the RASSF1A gene promoter in Uigur women with cervical squamous cell carcinoma. Tumori 2009; 95: 76-80.
9. MANAVI M, HUDELIST G, FINK-RETTER A et al. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma. Gynecol Oncol 2007; 105: 418-426. doi:10.1016/j.ygyno.2006.12.032
10. GRIGSBY PW, WATSON M, POWELL MA, et al. Gene expression patterns in advanced human cervical cancer. Int J Gynecol Cancer 2006; 16: 562-567. doi:10.1111/j.1525-1438.2006.00389.x
11. KIM TJ, CHOI JJ, KIM WY, et al. Gene expression profiling for the prediction of lymph node metastasis in patients with cervical cancer. Cancer Sci 2008; 99: 31-38.
12. LU D, TAWFIK O, PANTAZIS C et al. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression. Gynecol Oncol 1999; 75: 84-90. doi:10.1006/gyno.1999.5517
13. BIRD JG, SHARMA S, ROSHWALB SC et al. Functional analysis of CbpA, a DnaJ homolog and nucleoid-associated DNA-binding protein. J Biol Chem 2006; 281: 34349-34356. doi:10.1074/jbc.M603365200
14. Tabuchi Y, Ando H, Takasaki I et al. Identification of genes responsive to low intensity pulsed ultrasound in a human leukemia cell line Molt-4. Cancer Lett 2007; 246: 149-156. doi:10.1016/j.canlet.2006.02.011
15. HE M, RUTLEDGE SL, KELLY DR et al. A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. Am J Hum Genet 2007; 81: 87-103. doi:10.1086/ 519219
16. SOON PS, LIBE R, BENN DE et al. Loss of Heterozygosity of 17p13, With Possible Involvement of ACADVL and ALOX15B, in the Pathogenesis of Adrenocortical Tumors. Ann Surg 2008; 247: 157-164. doi:10.1097/SLA.0b013e318153ff55
17. TOMIZAWA M, HORIE H, YAMAMOTO H et al. Reciprocal expression of CCAAT/enhancer binding proteins alpha and beta in hepatoblastomas and its prognostic significance. Oncol Rep 2007; 17: 341-344.
18. YANG G, XU Y, CHEN X et al. IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene 2007; 26: 594-603. doi:10.1038/sj.onc.1209807
19. AKYERLI CB, BEKSAC M, HOLKO M et al. Expression of IFITM1 in chronic myeloid leukemia patients. Leuk Res 2005; 29: 283-286. doi:10.1016/j.leukres.2004.07.007